{"title":"颈动脉钙化作为全身血管事件的预测因子。","authors":"Noritaka Sano, Tamaki Kobayashi, Hiroharu Kataoka, Akiko Ishigami, Yusuke Shimahara, Naomi Morita, Masanobu Yamada, Kunihiro Nishimura, Koji Iihara","doi":"10.1177/1358863X251325808","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Coronary calcification is a well-known predictor of coronary events, yet the impact of carotid artery calcification on systemic vascular events (e.g., cerebral ischemic, coronary, and peripheral artery events) remains unclear. The aim of this study was to determine whether carotid calcification can be used to predict systemic vascular events.</p><p><strong>Methods: </strong>This single-center, retrospective cohort study included 194 patients who had a history of vascular disease, including carotid stenosis or occlusion, coronary artery disease, valvular heart disease, ischemic stroke, or transient ischemic attack. We collected data pertaining to risk factors and laboratory parameters. Calcification of the carotid arteries was assessed via whole-body computed tomography, and the modified carotid Agatston calcium score (CCS) was determined. Participants were divided into two CCS groups according to the cut-off value determined via receiver operating characteristic curve analysis; high CCS ≥ 126 and low CCS < 126. Coronary, ischemic cerebrovascular, and peripheral vascular events were recorded over a 5-year follow-up period, and their incidence was compared between the groups using Cox proportional hazards regression analysis.</p><p><strong>Results: </strong>Older age, hypertension, and chronic kidney disease had a significant positive impact on the CCS. Systemic vascular events (hazard ratio [HR]: 2.70, CI: 1.07-6.79, <i>p</i> = 0.022), coronary events (HR: 4.29, CI: 0.87-21.1, <i>p</i> = 0.045), and peripheral vascular events (<i>p</i> = 0.032) were significantly more frequent in the high versus low CCS group.</p><p><strong>Conclusion: </strong>The CCS may be a useful tool for predicting future systemic vascular events, including those related to coronary and peripheral artery diseases.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"1358863X251325808"},"PeriodicalIF":3.0000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Carotid artery calcification as a predictor of systemic vascular events.\",\"authors\":\"Noritaka Sano, Tamaki Kobayashi, Hiroharu Kataoka, Akiko Ishigami, Yusuke Shimahara, Naomi Morita, Masanobu Yamada, Kunihiro Nishimura, Koji Iihara\",\"doi\":\"10.1177/1358863X251325808\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Coronary calcification is a well-known predictor of coronary events, yet the impact of carotid artery calcification on systemic vascular events (e.g., cerebral ischemic, coronary, and peripheral artery events) remains unclear. The aim of this study was to determine whether carotid calcification can be used to predict systemic vascular events.</p><p><strong>Methods: </strong>This single-center, retrospective cohort study included 194 patients who had a history of vascular disease, including carotid stenosis or occlusion, coronary artery disease, valvular heart disease, ischemic stroke, or transient ischemic attack. We collected data pertaining to risk factors and laboratory parameters. Calcification of the carotid arteries was assessed via whole-body computed tomography, and the modified carotid Agatston calcium score (CCS) was determined. Participants were divided into two CCS groups according to the cut-off value determined via receiver operating characteristic curve analysis; high CCS ≥ 126 and low CCS < 126. Coronary, ischemic cerebrovascular, and peripheral vascular events were recorded over a 5-year follow-up period, and their incidence was compared between the groups using Cox proportional hazards regression analysis.</p><p><strong>Results: </strong>Older age, hypertension, and chronic kidney disease had a significant positive impact on the CCS. Systemic vascular events (hazard ratio [HR]: 2.70, CI: 1.07-6.79, <i>p</i> = 0.022), coronary events (HR: 4.29, CI: 0.87-21.1, <i>p</i> = 0.045), and peripheral vascular events (<i>p</i> = 0.032) were significantly more frequent in the high versus low CCS group.</p><p><strong>Conclusion: </strong>The CCS may be a useful tool for predicting future systemic vascular events, including those related to coronary and peripheral artery diseases.</p>\",\"PeriodicalId\":23604,\"journal\":{\"name\":\"Vascular Medicine\",\"volume\":\" \",\"pages\":\"1358863X251325808\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/1358863X251325808\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1358863X251325808","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
背景:冠状动脉钙化是众所周知的冠状动脉事件的预测因子,然而颈动脉钙化对全身血管事件(如脑缺血、冠状动脉和外周动脉事件)的影响尚不清楚。这项研究的目的是确定颈动脉钙化是否可以用来预测全身血管事件。方法:这项单中心、回顾性队列研究纳入了194例有血管疾病史的患者,包括颈动脉狭窄或闭塞、冠状动脉疾病、瓣膜性心脏病、缺血性卒中或短暂性脑缺血发作。我们收集了有关危险因素和实验室参数的数据。通过全身计算机断层扫描评估颈动脉钙化情况,并测定改良颈动脉Agatston钙评分(CCS)。根据受试者工作特征曲线分析确定的临界值将受试者分为两个CCS组;高CCS≥126,低CCS < 126。在5年的随访期间记录冠状动脉、缺血性脑血管和外周血管事件,并使用Cox比例风险回归分析比较各组之间的发生率。结果:年龄、高血压和慢性肾脏疾病对CCS有显著的正影响。全身血管事件(危险比[HR]: 2.70, CI: 1.07-6.79, p = 0.022)、冠状动脉事件(危险比[HR]: 4.29, CI: 0.87-21.1, p = 0.045)和周围血管事件(p = 0.032)在高CCS组比低CCS组明显更频繁。结论:CCS可能是预测未来全身血管事件的有用工具,包括与冠状动脉和外周动脉疾病相关的血管事件。
Carotid artery calcification as a predictor of systemic vascular events.
Background: Coronary calcification is a well-known predictor of coronary events, yet the impact of carotid artery calcification on systemic vascular events (e.g., cerebral ischemic, coronary, and peripheral artery events) remains unclear. The aim of this study was to determine whether carotid calcification can be used to predict systemic vascular events.
Methods: This single-center, retrospective cohort study included 194 patients who had a history of vascular disease, including carotid stenosis or occlusion, coronary artery disease, valvular heart disease, ischemic stroke, or transient ischemic attack. We collected data pertaining to risk factors and laboratory parameters. Calcification of the carotid arteries was assessed via whole-body computed tomography, and the modified carotid Agatston calcium score (CCS) was determined. Participants were divided into two CCS groups according to the cut-off value determined via receiver operating characteristic curve analysis; high CCS ≥ 126 and low CCS < 126. Coronary, ischemic cerebrovascular, and peripheral vascular events were recorded over a 5-year follow-up period, and their incidence was compared between the groups using Cox proportional hazards regression analysis.
Results: Older age, hypertension, and chronic kidney disease had a significant positive impact on the CCS. Systemic vascular events (hazard ratio [HR]: 2.70, CI: 1.07-6.79, p = 0.022), coronary events (HR: 4.29, CI: 0.87-21.1, p = 0.045), and peripheral vascular events (p = 0.032) were significantly more frequent in the high versus low CCS group.
Conclusion: The CCS may be a useful tool for predicting future systemic vascular events, including those related to coronary and peripheral artery diseases.
期刊介绍:
The premier, ISI-ranked journal of vascular medicine. Integrates the latest research in vascular biology with advancements for the practice of vascular medicine and vascular surgery. It features original research and reviews on vascular biology, epidemiology, diagnosis, medical treatment and interventions for vascular disease. A member of the Committee on Publication Ethics (COPE)